+ Site Statistics
References:
54,258,434
Abstracts:
29,560,870
PMIDs:
28,072,757
+ Search Articles
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ PDF Full Text
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Translate
+ Recently Requested

Evaluation of female intrapelvic tumors by clinical proton MR spectroscopy



Evaluation of female intrapelvic tumors by clinical proton MR spectroscopy



Journal of Magnetic Resonance Imaging 13(6): 912-917



We measured metabolites in large tumors of the female pelvis (23 cases total: 6 malignant cases, 17 benign cases) using single-voxel proton magnetic resonance (MR) spectroscopy and evaluated the clinical significance of this method in the differential diagnosis of female pelvic tumors. The characteristically obtained signal was lactate, which was detected not only in all the malignant tumors but also in some of the benign tumors. However, the lactate signals of the malignant tumors tended to form higher peaks than those of benign tumors, which was a finding consistent with the result of the earlier in vitro study reported in ovarian tumors. The signal of choline-containing compounds (Cho) was found only in solid tumors, and the signal intensity varied among different histological types of tumors, possibly reflecting metabolic activity of the cell membrane. We considered that proton MR spectroscopy (MRS) of intrapelvic tumors would be useful for the diagnosis of the nature of female intrapelvic tumors. J. Magn. Reson. Imaging 2001;13:912-917.

(PDF emailed within 0-6 h: $19.90)

Accession: 046009797

Download citation: RISBibTeXText

PMID: 11382952

DOI: 10.1002/jmri.1130


Related references

Clinical evaluation of choline measurement by proton MR spectroscopy in patients with malignant tumors. Radiation Medicine 22(3): 148-154, 2004

Clinical applications of proton magnetic resonance spectroscopy in the evaluation of common intracranial tumors. Topics in Magnetic Resonance Imaging 10(2): 104-113, 1999

Noninvasive evaluation of malignancy of brain tumors with proton MR spectroscopy. Ajnr. American Journal of Neuroradiology 17(4): 737-747, 1996

Evaluation of ovarian tumors by proton magnetic resonance spectroscopy at three Tesla. Investigative Radiology 43(10): 745-751, 2008

Proton magnetic resonance spectroscopy (1H-MRS) for the diagnosis of brain tumors and the evaluation of treatment. Neuro-Chirurgie 51(3-4 Pt 2): 299-308, 2005

Clinical use of proton magnetic resonance spectroscopy in brain tumors and adjacent tissues. Vestnik Rentgenologii i Radiologii: 39-50, 2014

In vivo proton spectroscopy of human intracranial tumors at 1.5 tesla preliminary experience at a clinical installation. Acta Radiologica (Copenhagen) 32(2): 95-99, 1991

Clinical application of proton magnetic resonance spectroscopy for differential diagnosis of pediatric posterior fossa tumors. Neurologia i Neurochirurgia Polska 35 Suppl 5: 19-25, 2002

Combination of single-voxel proton MR spectroscopy and apparent diffusion coefficient calculation in the evaluation of common brain tumors. Ajnr. American Journal of Neuroradiology 24(2): 225-233, 2003

Efficacy of proton magnetic resonance spectroscopy in clinical decision making for patients with suspected malignant brain tumors. Journal of Neuro-Oncology 45(1): 69-81, 2000

Proton magnetic resonance spectroscopy of small regions (1 mL) localized inside superficial human tumors. A clinical feasibility study. Nmr in Biomedicine 3(5): 227-232, 1990

Ex vivo two-dimensional proton nuclear magnetic resonance spectroscopy of smooth muscle tumors: advantages of total correlated spectroscopy over homonuclear J-correlated spectroscopy. Cancer Research 54(23): 6037-6040, 1994

Clinical application of PGA-tube for regeneration of intrapelvic nerves during extended surgery for intrapelvic recurrent rectal cancer. Gan to Kagaku Ryoho. Cancer & ChemoTherapy 29(12): 2202-2204, 2002

Clinical treatment during radiotherapy of intracranial, gastrointestinal and intrapelvic tumors. Medizinische Monatsschrift 17: 354-356, 1963

Proton MR spectroscopy in patients with neurofibromatosis type 1: evaluation of hamartomas and clinical correlation. Ajnr. American Journal of Neuroradiology 16(1): 141-147, 1995